4d
GlobalData on MSNKeymed’s Stapokibart approved by NMPA for seasonal allergic rhinitisFailed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...
According to Statifacts, the global allergy diagnostic market size is calculated at USD 6,711 million in 2025 and is expected ...
Q4 2024 Earnings Call Transcript February 7, 2025 Operator: Ladies and gentlemen, thank you for standing by. Welcome to ...
4d
Health on MSN10 Health Conditions Ginger Can Help Treat NaturallyGinger is known for its soothing effects on the stomach, and can effectively relieve nausea. It may also play a role in ...
Cases of flu-like illnesses and viral infections have been on the rise in the city in recent weeks, with recovery periods ...
Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...
Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
A meeting of the board of directors of the company is scheduled to be held on February 11, 2025, to consider and approve the ...
I have an allergic reaction when I eat melon soup” sounded like a joke till Majorie Konye was rushed to an emergency ward of a general hospital. We often ...
Keymed Biosciences Announces Approval of Stapokibart For the Treatment of Seasonal Allergic Rhinitis
CHENGDU, China I 8, 2025 I Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has ...
Hydroxyzine and Benadryl are both sedating antihistamines. They share many similarities but have different approved uses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results